Bibliography

Found 8 results

Filters: Keyword is Nerve Tissue Proteins [Clear All Filters]

2020

Velasquez S, Prevedel L, Valdebenito S, Gorska AMaria, Golovko M, Khan N, Geiger J, Eugenin EA. Circulating levels of ATP is a biomarker of HIV cognitive impairment. EBioMedicine. 2020 ;51:102503.

2019

Pulliam L, Sun B, Mustapic M, Chawla S, Kapogiannis D. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease. J Neurovirol. 2019 ;25(5):702-709.

2017

Curley P, Rajoli RKR, Moss DM, Liptrott NJ, Letendre S, Owen A, Siccardi M. Efavirenz Is Predicted To Accumulate in Brain Tissue: an In Silico, In Vitro, and In Vivo Investigation. Antimicrob Agents Chemother. 2017 ;61(1).

2016

Fields JA, Overk C, Adame A, Florio J, Mante M, Pineda A, Desplats P, Rockenstein E, Achim C, Masliah E. Neuroprotective effects of the immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity. J Neuroinflammation. 2016 ;13(1):120.

2014

Lucas C-H, Calvez M, Babu R, Brown A. Altered subcellular localization of the NeuN/Rbfox3 RNA splicing factor in HIV-associated neurocognitive disorders (HAND). Neurosci Lett. 2014 ;558:97-102.

2013

Desplats P, Dumaop W, Smith DM, Adame A, Everall I, Letendre S, Ellis RJ, Cherner M, Grant I, Masliah E. Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology. 2013 ;80(15):1415-23.

2007

Opii WO, Sultana R, Abdul HM, Ansari MA, Nath A, Butterfield DA. Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)–2',3'-dideoxycytidine (ddC): relevance to HIV-dementia. Experimental Neurology [Internet]. 2007 ;204(1):29-38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17069802

2003

Langford D, Masliah E. The emerging role of infectious pathogens in neurodegenerative diseases. Experimental Neurology [Internet]. 2003 ;184(2):553-555. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14769347